John Militello, CPA

John Militello, CPA

Principal Accounting Officer and Former Interim Principal Financial Officer, Vice PresidentatRocket Pharmaceuticals· In proxies 2022–2024

Pay in FY2024-23% from the year before · Rocket Pharmaceuticals stock -58.1% the same year

John Militello, CPA was paid $1.2M in FY2024 (Dec), down 23%. Rocket Pharmaceuticals stock fell 58.1% that year.

Pay$100 in the stock at the end of FY21 → $58
Pay is from the Summary Compensation Table of each Rocket Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rocket PharmaceuticalsPublic company · 4 yr
    • Principal Accounting Officer and Former Interim Principal Financial Officer, Vice President2022 – Present · 4 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?